Table 6.
Parameter estimates for change in outcomes over time
| Study outcomea | Tests of linear trends | ||
|---|---|---|---|
| Time period | Estimate (SE) | LRTa | |
| Wisepill adherence | |||
| Active treatment | Weekly (baseline to 4-month) | 0.14 (0.44) | χ2(2) = 22.15** |
| Follow up | Weekly (4-month to 8-month) | − 1.33 (0.69) | χ2(2) = 56.42** |
| Self-report adherence | |||
| Active treatment | Weekly (treatment phase) | 0.06 (0.02)** | χ2(2) = 1.81 |
| Full study period | Major assessments only | 0.87 (0.30)** | χ2(2) = 5.18 |
| Positive affect | |||
| Active treatment | Weekly (treatment phase) | 0.16 (0.11) | χ2(2) = 29.24** |
| Negative affect | |||
| Active treatment | Weekly (treatment phase) | − 0.28 (0.06)** | χ2(2) = 1.26 |
| Study outcomeb | Non-linear comparisons | |
|---|---|---|
| Baseline vs. 4-month | Baseline vs. 8-month | |
| Log PVL | − 1.13 (0.30)** | − 0.93 (0.32)** |
| Positive affect | 3.43 (1.77) | 3.84 (1.80)* |
| Negative affect | − 4.34 (1.35)** | − 0.77 (1.37) |
| PHQ depression | − 1.87 (1.03) | − 1.60 (1.05) |
The HLM parameter estimates are reported, followed by the standard error in parentheses
The results of the LRT determine whether we retained a fixed effects only model or if we retained the random effects as well for the linear test. A significant finding on the LRT means that we included the fixed and random effects in the linear test
Reference = baseline
Significant at p < .05
Significant at p < .01